Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dana Villenes"'
Autor:
Leigh C. Casadaban, Ajay V. Maker, Mebea Aklilu, Dana Villenes, Garth H. Rauscher, Sally Freels
Publikováno v:
Cancer. 122:3277-3287
BACKGROUND The role of adjuvant chemotherapy in patients with stage II colon cancer remains to be elucidated and its use varies between patients and institutions. Currently, clinical guidelines suggest discussing adjuvant chemotherapy for patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6411a68b4319a476c5f250658e68663a
https://doi.org/10.1002/cncr.30181
https://doi.org/10.1002/cncr.30181
Autor:
Leigh, Casadaban, Garth, Rauscher, Mebea, Aklilu, Dana, Villenes, Sally, Freels, Ajay V, Maker
Publikováno v:
Cancer. 122(21)
The role of adjuvant chemotherapy in patients with stage II colon cancer remains to be elucidated and its use varies between patients and institutions. Currently, clinical guidelines suggest discussing adjuvant chemotherapy for patients with high-ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc2db038839388cb5626ec83fdbf68db
https://pubmed.ncbi.nlm.nih.gov/27417445
https://pubmed.ncbi.nlm.nih.gov/27417445
Publikováno v:
Journal of Clinical Oncology. 33:671-671
671 Background: Patients are often selected for adjuvant therapy after resection of stage II colon cancer based on the presence of poor risk factors. However, the survival advantage of chemotherapy in this population is unclear and there remains vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c63748cdd6d30a0fa6539661679e953
https://doi.org/10.1200/jco.2015.33.3_suppl.671
https://doi.org/10.1200/jco.2015.33.3_suppl.671